Sponsor pipeline

Pediatric Brain Tumor Consortium clinical trial pipeline

2 active trials 0 recruiting 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-12

Primary completion pushed: 2026-03-31 → 2026-10-01
Completion pushed: 2026-03-31 → 2026-12-31

NCT04201457 A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG… · Phase 1/2

Phase 1/2		1
Phase 2		1

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT04743661	131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma	Recurrent Medulloblastoma	Active, Not Recruiting	2026-07-28
Phase 1/2
NCT04201457	A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG…	Low Grade Glioma (LGG) of Brain With BRAF Aberration	Active, Not Recruiting	2026-09-11

Get alerts when Pediatric Brain Tumor Consortium's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.